Janssen, R A <br/><br/>
Immunomodulatory effects of intravenous BIS-1 F(ab')2 administration in renal cell cancer patients.  [electronic resource] 

 -  British journal of cancer  Sep 1995 
 - 795-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0007-0920 
<br/><br/><label>Standard No.: </label>10.1038/bjc.1995.414  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--metabolism<br/>Antibodies, Bispecific--metabolism<br/>Antigens, Neoplasm--pharmacology<br/>Carcinoma, Renal Cell--immunology<br/>Cell Adhesion Molecules--pharmacology<br/>Epithelial Cell Adhesion Molecule<br/>Humans<br/>Immunoglobulin Fragments--metabolism<br/>Immunotherapy, Active<br/>Injections, Intravenous<br/>Interleukin-2--therapeutic use<br/>Kidney Neoplasms--immunology<br/>Leukopenia--chemically induced<br/>Lymphocyte Activation--drug effects<br/>T-Lymphocytes--immunology<br/>Tumor Necrosis Factor-alpha--metabolism